[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-studies-list:{\"conditionNormalized\":\"temporomandibular-disorders-tmds\",\"overallStatus\":[\"RECRUITING\",\"AVAILABLE\",\"NOT_YET_RECRUITING\"],\"orderBy\":\"LastUpdateSubmitDate:desc\",\"size\":25,\"offset\":0}":3,"health-study-condition:temporomandibular-disorders-tmds":27},{"pageToken":4,"total":5,"offset":6,"count":5,"results":7},null,8,0,[8,47,69,95,128,155,188,221],{"id":9,"slug":10,"hasResults":11,"nctId":12,"briefTitle":13,"officialTitle":14,"acronym":4,"eligibilityCriteria":15,"healthyVolunteers":11,"sex":16,"minAge":17,"maxAge":18,"enrollmentInfo":19,"targetDuration":4,"studyType":22,"phases":23,"briefSummary":25,"conditions":26,"keywords":30,"overallStatus":34,"whyStopped":4,"lastUpdateSubmitDate":35,"lastUpdatePostDateStruct":36,"startDateStruct":39,"completionDateStruct":41,"leadSponsor":43,"locationsCount":46},"100640819","peloid-therapy-in-temporomandibular-joint-dysfunction-100640819",false,"NCT07576582","Peloid Therapy in Temporomandibular Joint Dysfunction","The Effect of Peloid Therapy on Pain and Functional Outcomes in Patients With Temporomandibular Joint Dysfunction","Inclusion Criteria:\n\n* Age between 18 and 65 years\n* Diagnosis of temporomandibular joint dysfunction based on DC\u002FTMD criteria\n* Presence of TMJ-related pain for at least 4 weeks\n* Baseline pain intensity ≥3 on a 0-10 visual analog scale\n* Ability to provide written informed consent\n\nExclusion Criteria:\n\n* History of temporomandibular joint trauma, tumor, active infection, or acute inflammation\n* Previous temporomandibular joint surgery\n* Presence of systemic inflammatory rheumatologic disease\n* Pregnancy\n* Open wound, active dermatitis, or skin condition preventing peloid application at the treatment site\n* Injection therapy (e.g., botulinum toxin) or regular physical therapy for TMJ within the past 3 months\n* Any clinical or behavioral condition that may interfere with study compliance","ALL","18 Years","65 Years",{"count":20,"type":21},40,"ESTIMATED","INTERVENTIONAL",[24],"NA","This prospective, single-group clinical study will evaluate whether local peloid therapy improves pain and jaw function in adults with temporomandibular joint dysfunction. Participants will receive peloid therapy applied to the temporomandibular joint region and masticatory muscles for 20 minutes per session, 5 days per week, for 2 weeks. Pain and functional outcomes will be measured at baseline and at the end of treatment using validated clinical scales, including the Jaw Functional Limitation Scale-8, visual analog scale pain scores, Fonseca index, maximum mouth opening, and secondary otalgia assessment.",[27,28,29],"Temporomandibular Disorders (TMDs)","Pain","Otalgia",[31,32,33],"TMJ Disorders","pain","otalgia","RECRUITING","2026-06-29",{"date":37,"type":38},"2026-07-02","ACTUAL",{"date":40,"type":38},"2026-04-01",{"date":42,"type":21},"2027-02-01",{"name":44,"class":45},"Uşak University","OTHER",1,{"id":48,"slug":49,"hasResults":11,"nctId":50,"briefTitle":51,"officialTitle":51,"acronym":4,"eligibilityCriteria":52,"healthyVolunteers":11,"sex":16,"minAge":17,"maxAge":53,"enrollmentInfo":54,"targetDuration":4,"studyType":22,"phases":56,"briefSummary":57,"conditions":58,"keywords":4,"overallStatus":59,"whyStopped":4,"lastUpdateSubmitDate":60,"lastUpdatePostDateStruct":61,"startDateStruct":63,"completionDateStruct":65,"leadSponsor":67,"locationsCount":4},"100642381","effects-of-cervical-manual-therapy-for-temporomandibular-disorders-with-myalgia-100642381","NCT07647887","Effects of Cervical Manual Therapy for Temporomandibular Disorders With Myalgia","Inclusion Criteria:\n\n* Diagnosed with myogenous TMDs, defined as chronic myalgia (lasting \\>3 months continuously or \\> 6 months intermittently) 90 with or without accompanying arthralgia according to DC\u002FTMD criteria\n* A visual analogue scale (VAS) score of 3 or greater at baseline\n* 18 to 60 years of age\n\nExclusion Criteria:\n\n* Diagnosed with disc displacement without reduction or degenerative joint disease according to the DC\u002FTMD criteria\n* A diagnosis of systemic diseases such as fibromyalgia, rheumatoid arthritis, systemic erythematous lupus, or psoriatic arthritis\n* A diagnosis of neurological disorders (e.g., trigeminal neuralgia, cervical radiculopathy, or myelopathy)\n* Evidence of central nervous system involvement (positive pathological reflexes)\n* A history of traumatic injuries (e.g., contusion, fracture, or whiplash injury) in the last 6 weeks\n* Signs of vertebral artery insufficiency or upper cervical instability revealed by physical examination\n* Receiving cervical spine mobilization or manipulation or acupuncture for their TMDs within the last 1 week\n* any contraindication to TMS","60 Years",{"count":55,"type":21},48,[24],"Background: Temporomandibular disorders (TMDs) are the leading cause of non-odontogenic orofacial pain interfering with daily activities. TMDs consist of a group of conditions affecting the masticatory muscles, the temporomandibular joint (TMJ), or the associated structures. Previous studies showed alterations in TMJ kinematics, cortical excitability, electromyographic (EMG) activity of the masticatory muscles, and tongue pressure in individuals with TMDs compared to healthy controls. Furthermore, several studies have demonstrated that manual therapy applied to the cervical joint could reduce pain and improve jaw function in individuals with TMDs. However, the effects of upper cervical mobilization on TMJ kinematics, cortical excitability, tongue pressure, and EMG of masticatory muscles during mouth opening in individuals with myogenous TMDs remain unknown.\n\nPurpose: This study aims to investigate the immediate effects of upper cervical mobilization on TMJ kinematics, EMG of masticatory system muscles, cortical excitability, and tongue pressure in individuals with myogenous TMDs.\n\nMethods: A randomized controlled trial will be conducted with a total sample size of 48 participants. Individuals diagnosed with myogenous TMDs, defined as chronic myalgia (lasting \\>3 months continuously or \\> 6 months intermittently) according to the Diagnostic Criteria for Temporomandibular Disorders, will be recruited for this study. Participants will be randomly assigned to either the experimental or the control group, stratified by age and sex. The experimental group will receive a single session of upper cervical mobilization, while the control group will receive a placebo maneuver. The primary outcomes will include TMJ kinematics and EMG activity of the masseter and suprahyoid muscles, while the secondary outcomes will include cortical excitability, tongue pressure, pain intensity, and upper cervical mobility. All measurements will be taken before and immediately after the intervention.\n\nStatistical analysis: The continuous and categorical variables of clinical and demographic characteristics will be analyzed by an independent t test\u002FMann-Whitney U test and a Chi-square test, respectively. A 2×2 mixed-model analysis of variance (ANOVA) will be used to analyze the outcome measures and to test the main effects and interactions between time and group. If there is a significant interaction effect, post hoc pairwise comparisons with Bonferroni correction will be used. The alpha level is set at 0.05.",[27],"NOT_YET_RECRUITING","2026-06-09",{"date":62,"type":38},"2026-06-15",{"date":64,"type":21},"2026-07-01",{"date":66,"type":21},"2027-12-31",{"name":68,"class":45},"National Yang Ming Chiao Tung University",{"id":70,"slug":71,"hasResults":11,"nctId":72,"briefTitle":73,"officialTitle":74,"acronym":4,"eligibilityCriteria":75,"healthyVolunteers":11,"sex":16,"minAge":17,"maxAge":53,"enrollmentInfo":76,"targetDuration":4,"studyType":22,"phases":78,"briefSummary":79,"conditions":80,"keywords":81,"overallStatus":59,"whyStopped":4,"lastUpdateSubmitDate":86,"lastUpdatePostDateStruct":87,"startDateStruct":89,"completionDateStruct":91,"leadSponsor":93,"locationsCount":4},"100637011","hard-splint-vs-conservative-therapy-for-tmj-pain-management-100637011","NCT07573137","Hard Splint Vs Conservative Therapy for TMJ Pain Management","Efficacy of Hard Splint Vs Conservative Therapy in the Pain Management of Temporomandibular Joint Disorders","Inclusion Criteria:\n\n* Patients diagnosed with TMJ disorders based on clinical examination. Patients willing to participate and provide informed consent.\n\nExclusion Criteria:\n\n* Patient with a history of recent TMJ surgery or trauma. Patients with systemic joint diseases (e.g Rheumatoid Arthritis, Osteoporosis, Osteopetrosis, Osteomalacia).\n\nPatients currently using other occlusal appliances or undergoing active orthodontic treatment.",{"count":77,"type":21},60,[24],"The purpose of this study is to compare the efficacy of a hard occlusal splint versus conservative therapy (using topical Ibuprofen gel and counseling) in the management of patients with temporomandibular (TMJ) joint disorders. The study aims to determine which treatment is more effective at reducing pain, measured by Visual Analogue Scale (VAS), at 1 week and 4 weeks post therapy.",[27],[82,83,84,85],"Hard Occlusal splint","Conservative therapy","Visual Analogue Scale","Facial pain","2026-05-13",{"date":88,"type":38},"2026-05-15",{"date":90,"type":21},"2026-05-01",{"date":92,"type":21},"2026-11-30",{"name":94,"class":45},"Khyber College of dentistry",{"id":96,"slug":97,"hasResults":11,"nctId":98,"briefTitle":99,"officialTitle":100,"acronym":101,"eligibilityCriteria":102,"healthyVolunteers":11,"sex":16,"minAge":17,"maxAge":103,"enrollmentInfo":104,"targetDuration":4,"studyType":22,"phases":106,"briefSummary":107,"conditions":108,"keywords":114,"overallStatus":59,"whyStopped":4,"lastUpdateSubmitDate":120,"lastUpdatePostDateStruct":121,"startDateStruct":122,"completionDateStruct":124,"leadSponsor":126,"locationsCount":46},"100636071","temporomandibular-disorder-tmd-diagnostic-concordance-between-physiotherapist-and-surgeon-100636071","NCT07560917","Temporomandibular Disorder (TMD) Diagnostic Concordance Between Physiotherapist and Surgeon","Improving Access and Care Quality for Temporomandibular Disorder Patients - a Prospective Study to Examine Diagnostic Concordance Between Advanced-practice Physical Therapist and Oral and Maxillofacial Surgeon","TMD","Inclusion Criteria:\n\n* Referred for new consultation at the MUHC TMJ clinic for temporomandibular joint (TMJ) pain or dysfunction\n* Residents of the province of Quebec and benefiaries of provincial universal health insurance coverage (Régie de l'Assurance Maladie du Québec - RAMQ)\n* Be able to understand and communicate in either French of English\n* Be legally capable of providing informed consent\n\nExclusion Criteria:\n\n* Presenting for a follow-up visit (i.e., not a new consultation)\n* Have undergone TMJ surgery within the past six months\n* Referred directly from a recognized orofacial pain dentist or oral medicine specialist\n* Referred for acute TMJ trauma requiring urgent management (e.g., fractures, dislocations)\n* Present with complex or multi-system pathology that could confound the diagnostic process and are not related to TMD","85 Years",{"count":105,"type":21},70,[24],"Jaw disorders is the leading cause in facial pain, affecting many people in the world. Despite many patients finding relief from conservative treatment, many get referred to the surgeon for an evaluation. In order to improve access to care and reduce wait times, a new advanced practice physiotherapist-led triage model is being studied.",[109,110,111,27,112,113],"Temporo-mandibular Dysfunction","Temporomandibular Disorder (TMD)","Temporomandibular Dysfunction (TMD)","Temporomandibular Joint and Muscle Disorder","Temporomandibular Joint",[101,115,116,117,118,119,113],"Physiotherapy","Physical Therapy","Oral and Maxillofacial Surgery","Diagnostic","TMJ","2026-04-28",{"date":90,"type":38},{"date":123,"type":21},"2026-09",{"date":125,"type":21},"2027-06",{"name":127,"class":45},"McGill University Health Centre\u002FResearch Institute of the McGill University Health Centre",{"id":129,"slug":130,"hasResults":11,"nctId":131,"briefTitle":132,"officialTitle":133,"acronym":4,"eligibilityCriteria":134,"healthyVolunteers":11,"sex":135,"minAge":17,"maxAge":136,"enrollmentInfo":137,"targetDuration":4,"studyType":22,"phases":139,"briefSummary":140,"conditions":141,"keywords":142,"overallStatus":59,"whyStopped":4,"lastUpdateSubmitDate":146,"lastUpdatePostDateStruct":147,"startDateStruct":149,"completionDateStruct":151,"leadSponsor":153,"locationsCount":4},"100615115","effects-of-vagus-nerve-stimulation-on-temporomandibular-disorders-100615115","NCT07288411","Effects of Vagus Nerve Stimulation on Temporomandibular Disorders.","Pilot Study of the Effects of Transcutaneous Non-Invasive Vagus Nerve Stimulation (nVNS) on Symptoms and Brain Mechanisms in Premenopausal Women With Temporomandibular Disorders (TMD)","Inclusion Criteria:\n\n* Ages 18-50\n* Premenopausal menstruating women\\*\n* Participants report or present with at least 1 of 3 cardinal signs of TMD: jaw pain, limited mouth opening, or TMJ noise.\n* Specific screening reveals clinical findings that require standard of care medically-indicated intra-articular procedure for management of symptoms including TMJ pain, intra-articular joint disorder leading to joint locking or limited mouth opening or displacement, and severe degenerative joint disease.\n* Must have a negative urine test for pregnancy\n* Ability to speak the English language fluently due to the standardized assessments involved\n* Right-handed (participants are limited to right-handed individuals to reduce variability in brain lateralization and ensure more consistent, interpretable data).\n\n  * Only premenopausal women are included to control for hormonal variability that may influence the results. Participants will be scheduled during their follicular phase based on self-reported last menstrual period to further reduce hormonal confounds.\n\nExclusion Criteria:\n\n* Medical condition, laboratory finding, or physical exam finding that precludes participation, such as systemic arthritides, juvenile idiopathic arthritis, idiopathic condylar resorption, connective tissue disorders, mandibular osteonecrosis, mandibular and condylar fractures, salivary gland disorders (incl. history of stones or swelling), neoplasms, neurologic\u002Fneuropathic, endocrine, or immune\u002Fautoimmune diseases and congenital or developmental disorders.\n* Pathologic processes found on imaging including neoplasm (Exception: disc displacements and osseous pathology including osteoarthritis\u002Fosteoarthrosis).\n* Radiation treatment to head and neck\n* Prior jaw or open TMJ (including contralateral joint) surgery including plication, chondroplasty, joint replacement, disectomy, and discoplasty.\n* Intra-articular therapies of TMJ being sampled that include arthrocentesis, visco-supplementation, and steroid, platelet-rich plasma\u002Fplatelet-rich fibrin administration within the last 6mo\n* Recent febrile illness within the past 8 weeks that precludes or delays participation by more than 90 days\n* Trauma to jaw in the last 2mo\n* Presence of non-TMD orofacial pain disorders excluding comorbidity of interest (fibromyalgia).\n* Pregnancy or lactation\n* Undergoing or previously undergone bone anabolic or other hormonal therapies for medical needs\n* Unable to participate due to language barrier or mental\u002Fintellectual incompetence\n* Use of antidepressant drugs unless the participants have been on a stable dose for 60 days.\n* Drug and\u002For alcohol abuse in the past year\n* Ongoing dental treatments requiring invasive procedures (e.g. implant placement, tooth extractions, etc.)\n* Recent dental treatments within past two weeks that required sustained mouth opening for more than 20 minutes.\n* Wearing removable or implant supported dentures or fixed orthodontic appliances\n* Unable or unwilling to give informed consent\n* Participation in another clinical study that interferes with participation in this study\n* Anything that would place the individual at increased risk or preclude the individual's full compliance with or completion of the study.\n* Presence of non-TMD orofacial pain disorders such as that from periodontal disease and carious lesions.\n* Presence of major psychiatric diagnosis such as schizophrenia, bipolar disorder, post-traumatic stress disorder, obsessive compulsive disorder, or current history of drug or alcohol abuse.\n* Individuals with current regular use of narcotics and\u002For opioids. Use of centrally acting medications that will interfere with neuroimaging testing, such as systemic steroids, opiate analgesics.\n* Smokes\u002FVapes tobacco more than 1\u002F3 pack per day","FEMALE","50 Years",{"count":138,"type":21},10,[24],"The study aims to examine the effects of transcutaneous non-invasive vagus nerve stimulation (nVNS) on symptoms and brain mechanisms in premenopausal women with temporomandibular disorders (TMD). Non-invasive vagus nerve stimulation (nVNS) is the most well researched and possibly the most effective non-invasive neuromodulation treatment for chronic pain conditions that targets the brain-gut-microbiome (BGM) axis.\n\nParticipants will be asked to come in for 2 in-clinic visits, at baseline and post treatment. Participants will also be asked to come in 2x\u002Fweek for 8 consecutive weeks to receive the nVNS treatment. The in-clinic visits will include physical measures, blood draw, saliva sample, and brain MRI. Participants will be asked to collect a stool sample at home and answer online questionnaires regarding, mood, pain, and health behaviors at home, prior to the in-clinic appointments.",[101,27],[101,143,144,145],"Temporomandibular Disorders","non-invasive vagus nerve stimulation","nVNS","2026-03-13",{"date":148,"type":38},"2026-03-17",{"date":150,"type":21},"2026-06-01",{"date":152,"type":21},"2026-12-31",{"name":154,"class":45},"Arpana Church",{"id":156,"slug":157,"hasResults":11,"nctId":158,"briefTitle":159,"officialTitle":160,"acronym":4,"eligibilityCriteria":161,"healthyVolunteers":11,"sex":16,"minAge":17,"maxAge":4,"enrollmentInfo":162,"targetDuration":4,"studyType":22,"phases":164,"briefSummary":165,"conditions":166,"keywords":170,"overallStatus":34,"whyStopped":4,"lastUpdateSubmitDate":178,"lastUpdatePostDateStruct":179,"startDateStruct":181,"completionDateStruct":183,"leadSponsor":185,"locationsCount":187},"100629437","comparing-the-effectiveness-of-online-vs-face-to-face-physiotherapy-for-treating-temporomandibular-disorders-100629437","NCT07474662","Comparing the Effectiveness of Online vs. Face-to-face Physiotherapy for Treating Temporomandibular Disorders","Comparing the Effectiveness of Online vs. One-on-one vs. Group Physiotherapy for Treating Myogenic Temporomandibular Disorders: A Randomized Controlled Trial","Inclusion Criteria:\n\n* Patients with myalgia\n\nExclusion Criteria:\n\n* Children, patients with systemic rheumatic diseases (RA, SLE..), previous jaw surgery or trauma",{"count":163,"type":21},90,[24],"Dentists and physiotherapists have two options for treating these conditions: splint therapy and physiotherapy. Right now, the gold standard is individual physiotherapy, which contains manual therapy and active exercises too. Since not many dentists and physiotherapists are experts in this area, patients have to wait for months or even years to get their treatment. Thanks to social media, patients can find many information about their condition while they are waiting, but it's our responsibility to provide safe and effective information. In view of this situation, our aim is to find out if online or group physiotherapy is as effective as individual physiotherapy.",[167,168,109,112,169,110,27],"Temporomandibular Disorders (TMD)","Orofacial Pain","TMD\u002FOrofacial Pain",[27,115,171,172,173,174,175,176,177],"Manual therapy","Online","Group physiotherapy","Individual physiotherapy","Video exercises","Telemedicine","Teledentistry","2026-03-11",{"date":180,"type":38},"2026-03-16",{"date":182,"type":21},"2026-03-01",{"date":184,"type":21},"2026-07-31",{"name":186,"class":45},"Semmelweis University",2,{"id":189,"slug":190,"hasResults":11,"nctId":191,"briefTitle":192,"officialTitle":193,"acronym":194,"eligibilityCriteria":195,"healthyVolunteers":11,"sex":16,"minAge":17,"maxAge":4,"enrollmentInfo":196,"targetDuration":4,"studyType":22,"phases":198,"briefSummary":199,"conditions":200,"keywords":202,"overallStatus":59,"whyStopped":4,"lastUpdateSubmitDate":212,"lastUpdatePostDateStruct":213,"startDateStruct":215,"completionDateStruct":217,"leadSponsor":219,"locationsCount":4},"100600254","epropp---ehealth-for-preventing-and-reducing-orofacial-pain-in-the-population-100600254","NCT07095101","ePROPP - eHealth for Preventing and Reducing Orofacial Pain in the Population","Effect and Cost-effectiveness of Smartphone-based Behavioural Intervention on Orofacial Pain","ePROPP","Inclusion criteria\n\n* Chronic orofacial pain, duration ≥3 months with a diagnosis of Myalgia according to the brief DC\u002FTMD.\n* Patients will be included even if they have one or more additional DC\u002FTMD diagnoses\n* Regular smartphone users\n* Understanding written and spoken Swedish\n* Age ≥ 18 years\n\nExclusion criteria\n\n* Other orofacial non-TMD pain conditions\n* Cognitive impairment.",{"count":197,"type":21},120,[24],"Pain in the orofacial region has a 10% prevalence in the general population and health care providers are therefore expected to encounter these patients on a daily basis. Chronic orofacial pain often presents as jaw pain related to overload of the jaw muscles and temporomandibular joints. The aim of this study is to evaluate the effectiveness of a smartphone-based behavioural intervention (Ecological Momentary Intervention, EMI) grounded in Cognitive Behavioural Therapy (CBT), compared to standard treatment with an occlusal splint and a waiting list control group.",[201,27],"Temporomandibular Joint Disorder",[27,203,204,205,176,206,207,208,209,210,211],"Myalgia","Facial Pain","Behavior therapy","Digital health","Occlusal splints","Cost-effectiveness analysis","Bruxism","Mobile applications","Cognitive Behavioral Therapy","2025-07-31",{"date":214,"type":38},"2025-08-05",{"date":216,"type":21},"2025-08-22",{"date":218,"type":21},"2028-12-31",{"name":220,"class":45},"Malmö University",{"id":222,"slug":223,"hasResults":11,"nctId":224,"briefTitle":225,"officialTitle":226,"acronym":4,"eligibilityCriteria":227,"healthyVolunteers":11,"sex":16,"minAge":17,"maxAge":18,"enrollmentInfo":228,"targetDuration":4,"studyType":22,"phases":230,"briefSummary":231,"conditions":232,"keywords":233,"overallStatus":59,"whyStopped":4,"lastUpdateSubmitDate":238,"lastUpdatePostDateStruct":239,"startDateStruct":241,"completionDateStruct":243,"leadSponsor":245,"locationsCount":46},"100597302","quality-of-life-and-sleep-in-patients-with-temporomandibular-disorders-100597302","NCT07056725","Quality of Life and Sleep in Patients With Temporomandibular Disorders","Quality of Life and Sleep in Patients With Temporomandibular Disorders. A Protocol for a Randomized Control Trial","Inclusion Criteria:\n\n* Adults between 18 and 65 years of age with subacute Temporomandibular Disorders (TMD).\n* Diagnosis of TMD based on: The Diagnostic Criteria for Temporomandibular Disorders (DC\u002FTMD). And The Research Diagnostic Criteria for Temporomandibular Disorders (RDC\u002FTMD).\n* Willingness to participate in the study and signing of the informed consent form.\n\nExclusion Criteria:\n\n* Individuals younger than 18 years or older than 65 years.\n* Medical history or systemic conditions, including: Diagnosis of neurological or neuromuscular disorders (such as multiple sclerosis, facial paralysis, trigeminal neuralgia). Systemic or inflammatory joint diseases (e.g., rheumatoid arthritis, systemic lupus erythematosus, fibromyalgia). Presence of severe psychiatric disorders. Previous diagnosis of cancer in the craniofacial or cervical region.\n* Previous interventions (e.g., surgery involving the TMJ or the orofacial and cervical regions).\n* History of trauma in the region, including mandibular trauma, whiplash injuries, or fractures in the area.\n* Pregnant or breastfeeding women.",{"count":229,"type":21},30,[24],"The aim of this study is to evaluate and compare the effects of two physiotherapeutic intervention programs on the quality of life in patients with Temporomandibular Disorders (TMD).\n\nStudy design: Randomized, longitudinal, and prospective clinical trial with two intervention groups.\n\nPopulation: Subjects aged 18-65 years with subacute temporomandibular disorders.",[27],[234,235,236,237],"Manual Therapy","Therapeutic Exercise","Quality of life","Quality of Sleep","2025-06-29",{"date":240,"type":38},"2025-07-09",{"date":242,"type":21},"2025-08",{"date":244,"type":21},"2026-01",{"name":246,"class":45},"University of Jaén"]